GIANT BIOGENE

Forecast & Rating17 analysts currently cover GIANT BIOGENE, with about 82.4% giving a positive rating — meaning they expect the stock to rise. The average price target is HK$41.07, about 34.1% upside from the current price of HK$30.62. Price targets range from HK$29.50 to HK$82.20 — a wide spread, showing clear disagreement over just how much GIANT BIOGENE can rise. Historically, about 95.7% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study GIANT BIOGENE closely still see room for the stock to rise. Data as of Jul 23, 2026; for reference only and not investment advice.